Skip to main content

Table 1 Patients’ characteristics and univariate analysis based on 12-month survival status

From: The day after intracerebral hemorrhage: platelet mass index as predictor of survival—a retrospective cohort study

Parameters

Mean ± SD;

N (%)

12-month survival

P

Yes (n = 29)

No (n = 30)

Gender

    

 Males

28 (47.5)

13 (44.8)

15 (50.0)

0.691

 Females

31 (52.5)

16 (55.2)

15 (50.0)

Age (years)

    

 Mean ± SD

75.7 ± 12.0

70.6 ± 11.4

80.7 ± 10.5

0.001

Arterial hypertension

    

 Yes

42 (69.5)

16 (55.2)

25 (83.3)

0.019

 No

18 (30.5)

13 (44.8)

5 (16.7)

CAD

    

 Yes

8 (13.6)

3 (10.3)

5 (16.7)

0.478

 No

51 (86.4)

26 (89.7)

25 (83.3)

Diabetes mellitus

    

 Yes

9 (15.3)

1 (3.4)

8 (26.7)

0.026

 No

50 (84.7)

28 (96.6)

22 (73.3)

Dyslipidemia

    

 Yes

23 (39.0)

9 (31.0)

14 (46.7)

0.288

 No

36 (61.0)

20 (69.0)

16 (53.3)

Antiplatelets

    

 Yes

14 (23.7)

7 (24.1)

7 (23.3)

0.942

 No

45 (76.3)

22 (75.9)

23 (76.7)

Anticoagulants

    

 Yes

7 (11.9)

3 (10.3)

4 (13.3)

1.000

 No

52 (88.1)

26 (89.7)

26 (86.7)

Admission time (h)

    

 Mean ± SD

13.6 ± 33.8

14.0 ± 35.0

13.3 ± 33.1

0.931

Hemoglobin (g/dL)

    

 Mean ± SD

13.3 ± 1.4

13.7 ± 1.1

12.8 ± 1.5

0.019

Glucose (mg/dL)

    

 Mean ± SD

124 ± 46

110 ± 25

138 ± 57

0.021

Potassium (mmol/L)

    

 Mean ± SD

3.97 ± 0.55

4.02 ± 0.49

3.93 ± 0.60

0.530

Sodium (mmol/L)

    

 Mean ± SD

141 ± 3

141 ± 4

141 ± 3

0.552

BUN (mg/dL)

    

  Mean ± SD

42.6 ± 27.0

42.7 ± 33.7

42.5 ± 19.1

0.971

Creatinine (mg/dL)

    

 Mean ± SD

0.97 ± 0.92

1.03 ± 1.17

0.91 ± 0.60

0.531

AST (IU/dL)

    

 Mean ± SD

21.2 ± 11.6

21.0 ± 11.6

21.4 ± 12.1

0.906

ALT (IU/dL)

    

 Mean ± SD

16.6 ± 12.5

19.1 ± 17.1

14.3 ± 5.8

0.151

pH

    

 Mean ± SD

7.40 ± 0.07

7.41 ± 0.06

7.40 ± 0.08

0.744

sPO2 (%)

    

 Mean ± SD

95.0 ± 2.9

95.9 ± 1.5

94.2 ± 3.6

0.023

Bicarbonates (mmol/L)

    

 Mean ± SD

23.2 ± 3.5

23.0 ± 3.3

23.3 ± 3.7

0.763

Lactates (mmol/L)

    

 Mean ± SD

1.85 ± 1.32

1.72 ± 1.53

1.97 ± 1.09

0.457

CRP (mg/dL)

    

 Mean ± SD

1.43 ± 1.54

1.15 ± 1.55

1.71 ± 1.50

0.168

Temperature (oC)

    

 Mean ± SD

36.2 ± 0.4

36.1 ± 0.3

36.2 ± 0.5

0.549

SBP (mmHg)

    

 Mean ± SD

171 ± 30

173 ± 31

168 ± 28

0.483

DBP (mmHg)

    

 Mean ± SD

94.3 ± 14.4

94.1 ± 15.3

94.4 ± 13.8

0.931

Pulse rate (min−1)

    

 Mean ± SD

86.8 ± 16.7

83.9 ± 16.8

89.5 ± 16.3

0.199

Hemorrhage volume (hematoma size) (cm3)

    

 Mean ± SD

25.1 ± 39.2

19.8 ± 18.0

30.3 ± 52.0

0.303

Intraventricular hemorrhage

    

 Yes

17 (28.8)

8 (27.6)

9 (30.0)

0.838

 No

42 (71.2)

21 (72.4)

21 (70.0)

Infratentorial origin

    

 Yes

5 (8.5)

1 (3.4)

4 (13.3)

0.353

 No

54 (91.5)

28 (96.6)

26 (86.7)

mRS

    

 Mean ± SD

3.69 ± 1.12

3.17 ± 0.93

4.20 ± 1.06

 < 0.001

ICH score

    

 Mean ± SD

1.95 ± 1.25

1.31 ± 0.89

2.57 ± 1.25

 < 0.001

Thrombocytopenia

    

 Yes

4 (6.8)

1 (3.4)

3 (10.0)

0.612

 No

55 (93.3)

28 (96.6)

27 (90.0)

Fresh Frozen Plasma

    

 Yes

0 (0.0)

0 (0.0)

0 (0.0)

ND

 No

59 (100.0)

29 (100.0)

30 (100.0)

Platelet transfusion

    

 Yes

0 (0.0)

0 (0.0)

0 (0.0)

ND

 No

59 (100.0)

29 (100.0)

30 (100.0)

  1. Bold vaues correspond to statistcally significant p-values
  2. SD Standard Deviation, ND not determined
  3. For scale variables
  4. For nominal variables
  5. Fisher exact test